new glp 1 medication The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for weight-loss medications From 'companion foods' to 'Nature's
Description
Saraiva FK, Sposito AC

In addition, Jardiance may interact with lithium, a mood stabilizer used to treat manic episodes of bipolar disorder

Feldman, M.D

More than half (54 percent) of patients using GLP-1s discontinue use within one year and 72 percent discontinue within two years

2024;25(5) doi: 10.1111/obr.13704
